Theravance Biopharma, Inc. (TBPH)
NASDAQ: TBPH · Real-Time Price · USD
14.54
+0.23 (1.64%)
Oct 31, 2025, 1:23 PM EDT - Market open

Revenue by Product

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202015 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Human Therapeutics
64.38M
Log In
Log In
Log In
Log In
Upgrade
Human Therapeutics Growth
12.12%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202015 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
United States
64.38M
Log In
Log In
Log In
Log In
Upgrade
United States Growth
12.55%
Log In
Log In
Log In
Log In
Upgrade
Europe
-
Log In
Log In
Log In
Log In
Upgrade
Europe Growth
-
Log In
Log In
Log In
Log In
Upgrade